RBC Capital maintained an Underperform rating and $5 price target on Palantir after the National Health Service awarded Palantir and four other IT professional services and consultant firms a GBP 330M contract over seven years. RBC views the announcement as “underwhelming,” as the contract was smaller than expected and is split between four other firms.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PLTR: